Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Trial Title: Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT ID: NCT05564377

Condition: Advanced Malignant Solid Neoplasm
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Locally Advanced Malignant Solid Neoplasm
Malignant Female Reproductive System Neoplasm
Metastatic HER2-Negative Breast Carcinoma
Metastatic Malignant Solid Neoplasm
Recurrent Endometrial Carcinoma
Recurrent Fallopian Tube Carcinoma
Recurrent Malignant Female Reproductive System Neoplasm
Recurrent Malignant Solid Neoplasm
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma
Unresectable HER2-Negative Breast Carcinoma
Unresectable Malignant Solid Neoplasm

Conditions: Official terms:
Carcinoma
Breast Neoplasms
Neoplasms
Endometrial Neoplasms
Genital Neoplasms, Female
Recurrence
Leucovorin
Paclitaxel
Oxaliplatin
Fluorouracil
Albumin-Bound Paclitaxel
Fulvestrant
Olaparib
Palbociclib
Panitumumab
Ipatasertib
Sotorasib
Antineoplastic Agents, Immunological
Antibodies
Immunoglobulins
Antibodies, Monoclonal
Maleic acid
Nilotinib
Neratinib
Phosphoinositide-3 Kinase Inhibitors

Study type: Interventional

Study phase: Phase 2

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Single Group Assignment

Primary purpose: Screening

Masking: None (Open Label)

Intervention:

Intervention type: Drug
Intervention name: Alpelisib
Description: Given PO
Arm group label: EAY191-A2 (Cohort 1, Arm A)
Arm group label: EAY191-A2 (Cohort 2, Arm B)
Arm group label: EAY191-A2 (Cohort 3, Arm D)

Other name: BYL 719

Other name: BYL-719

Other name: BYL719

Other name: Phosphoinositide 3-kinase Inhibitor BYL719

Other name: Piqray

Other name: VIJOICE

Intervention type: Drug
Intervention name: Binimetinib
Description: Given PO
Arm group label: EAY191-A3 Monotherapy Cohort 1 (binimetinib)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)

Other name: ARRY 162

Other name: ARRY 438162

Other name: ARRY-162

Other name: ARRY-438162

Other name: ARRY162

Other name: ARRY438162

Other name: MEK 162

Other name: MEK-162

Other name: MEK162

Other name: Mektovi

Intervention type: Procedure
Intervention name: Biopsy
Description: Undergo biopsy
Arm group label: EAY191-A2 (Cohort 1, Arm A)
Arm group label: EAY191-A2 (Cohort 2, Arm B)
Arm group label: EAY191-A2 (Cohort 2, Arm C)
Arm group label: EAY191-A2 (Cohort 3, Arm D)
Arm group label: EAY191-A3 Combo Cohorts 1, 2, 3, 4 (palbociclib, binimetinib)
Arm group label: EAY191-A3 Monotherapy Cohort 1 (binimetinib)
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-E4 (taxane therapy)
Arm group label: EAY191-E5 Cohort I Arm A (sotorasib, panitumumab)
Arm group label: EAY191-E5 Cohort I Arm B (sotorasib)
Arm group label: EAY191-E5 Cohort II (sotorasib)
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort I (Arm II) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)
Arm group label: EAY191-N4 Arm II (RAS pathway mutations)
Arm group label: EAY191-N5 Arm I (neratinib maleate)
Arm group label: EAY191-N5 Arm II (neratinib maleate,palbociclib)
Arm group label: EAY191-S3 (activating AKT mutation)

Other name: BIOPSY_TYPE

Other name: Bx

Intervention type: Procedure
Intervention name: Biospecimen Collection
Description: Undergo blood collection
Arm group label: EAY191-A2 (Cohort 1, Arm A)
Arm group label: EAY191-A2 (Cohort 2, Arm B)
Arm group label: EAY191-A2 (Cohort 2, Arm C)
Arm group label: EAY191-A2 (Cohort 3, Arm D)
Arm group label: EAY191-A3 Combo Cohorts 1, 2, 3, 4 (palbociclib, binimetinib)
Arm group label: EAY191-A3 Monotherapy Cohort 1 (binimetinib)
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-E4 (taxane therapy)
Arm group label: EAY191-E5 Cohort I Arm A (sotorasib, panitumumab)
Arm group label: EAY191-E5 Cohort I Arm B (sotorasib)
Arm group label: EAY191-E5 Cohort II (sotorasib)
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort I (Arm II) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)
Arm group label: EAY191-N4 Arm II (RAS pathway mutations)
Arm group label: EAY191-N5 Arm I (neratinib maleate)
Arm group label: EAY191-N5 Arm II (neratinib maleate,palbociclib)
Arm group label: EAY191-S3 (activating AKT mutation)

Other name: Biological Sample Collection

Other name: Biospecimen Collected

Other name: Specimen Collection

Intervention type: Procedure
Intervention name: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)
Arm group label: EAY191-N4 Arm II (RAS pathway mutations)

Intervention type: Procedure
Intervention name: Bone Scan
Description: Undergo bone scan
Arm group label: EAY191-A2 (Cohort 1, Arm A)
Arm group label: EAY191-A2 (Cohort 2, Arm B)
Arm group label: EAY191-A2 (Cohort 2, Arm C)
Arm group label: EAY191-A2 (Cohort 3, Arm D)
Arm group label: EAY191-A3 Combo Cohorts 1, 2, 3, 4 (palbociclib, binimetinib)
Arm group label: EAY191-A3 Monotherapy Cohort 1 (binimetinib)
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort I (Arm II) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)

Other name: Bone Scintigraphy

Intervention type: Procedure
Intervention name: Computed Tomography
Description: Undergo CT
Arm group label: EAY191-A2 (Cohort 1, Arm A)
Arm group label: EAY191-A2 (Cohort 2, Arm B)
Arm group label: EAY191-A2 (Cohort 2, Arm C)
Arm group label: EAY191-A2 (Cohort 3, Arm D)
Arm group label: EAY191-A3 Combo Cohorts 1, 2, 3, 4 (palbociclib, binimetinib)
Arm group label: EAY191-A3 Monotherapy Cohort 1 (binimetinib)
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-E4 (taxane therapy)
Arm group label: EAY191-E5 Cohort I Arm A (sotorasib, panitumumab)
Arm group label: EAY191-E5 Cohort I Arm B (sotorasib)
Arm group label: EAY191-E5 Cohort II (sotorasib)
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort I (Arm II) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)
Arm group label: EAY191-N4 Arm II (RAS pathway mutations)
Arm group label: EAY191-N5 Arm I (neratinib maleate)
Arm group label: EAY191-N5 Arm II (neratinib maleate,palbociclib)
Arm group label: EAY191-S3 (activating AKT mutation)

Other name: CAT

Other name: CAT Scan

Other name: Computed Axial Tomography

Other name: Computerized Axial Tomography

Other name: Computerized axial tomography (procedure)

Other name: Computerized Tomography

Other name: Computerized Tomography (CT) scan

Other name: CT

Other name: CT Scan

Other name: tomography

Intervention type: Procedure
Intervention name: Echocardiography
Description: Undergo ECHO
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort I (Arm II) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)
Arm group label: EAY191-N4 Arm II (RAS pathway mutations)
Arm group label: EAY191-N5 Arm I (neratinib maleate)
Arm group label: EAY191-N5 Arm II (neratinib maleate,palbociclib)

Other name: EC

Intervention type: Drug
Intervention name: Fluorouracil
Description: Given IV
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)

Other name: 5 Fluorouracil

Other name: 5 Fluorouracilum

Other name: 5 FU

Other name: 5-Fluoro-2,4(1H, 3H)-pyrimidinedione

Other name: 5-Fluorouracil

Other name: 5-Fluracil

Other name: 5-Fu

Other name: 5FU

Other name: AccuSite

Other name: Carac

Other name: Fluoro Uracil

Other name: Fluouracil

Other name: Flurablastin

Other name: Fluracedyl

Other name: Fluracil

Other name: Fluril

Other name: Fluroblastin

Other name: Ribofluor

Other name: Ro 2-9757

Other name: Ro-2-9757

Intervention type: Drug
Intervention name: Fulvestrant
Description: Given IM
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort I (Arm II) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)

Other name: Faslodex

Other name: Faslodex(ICI 182,780)

Other name: ICI 182,780

Other name: ICI 182780

Other name: ICI-182780

Other name: ICI182780

Other name: ZD 9238

Other name: ZD-9238

Other name: ZD9238

Intervention type: Drug
Intervention name: Ipatasertib
Description: Given PO
Arm group label: EAY191-S3 (activating AKT mutation)

Other name: GDC 0068

Other name: GDC-0068

Other name: GDC0068

Other name: RG 7440

Other name: RG-7440

Other name: RG7440

Intervention type: Drug
Intervention name: Leucovorin
Description: Given IV
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)

Other name: Folinic acid

Intervention type: Procedure
Intervention name: Magnetic Resonance Imaging
Description: Undergo MRI
Arm group label: EAY191-A2 (Cohort 1, Arm A)
Arm group label: EAY191-A2 (Cohort 2, Arm B)
Arm group label: EAY191-A2 (Cohort 2, Arm C)
Arm group label: EAY191-A3 Combo Cohorts 1, 2, 3, 4 (palbociclib, binimetinib)
Arm group label: EAY191-A3 Monotherapy Cohort 1 (binimetinib)
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-E4 (taxane therapy)
Arm group label: EAY191-E5 Cohort I Arm A (sotorasib, panitumumab)
Arm group label: EAY191-E5 Cohort I Arm B (sotorasib)
Arm group label: EAY191-E5 Cohort II (sotorasib)
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort I (Arm II) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)
Arm group label: EAY191-N5 Arm I (neratinib maleate)
Arm group label: EAY191-N5 Arm II (neratinib maleate,palbociclib)
Arm group label: EAY191-S3 (activating AKT mutation)

Other name: Magnetic Resonance

Other name: Magnetic Resonance Imaging (MRI)

Other name: Magnetic resonance imaging (procedure)

Other name: Magnetic Resonance Imaging Scan

Other name: Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance

Other name: MR

Other name: MR Imaging

Other name: MRI

Other name: MRI Scan

Other name: MRIs

Other name: NMR Imaging

Other name: NMRI

Other name: Nuclear Magnetic Resonance Imaging

Other name: sMRI

Other name: Structural MRI

Intervention type: Procedure
Intervention name: Multigated Acquisition Scan
Description: Undergo MUGA
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-N2 Cohort I (Arm I) (NF1 mutations)
Arm group label: EAY191-N2 Cohort I (Arm II) (NF1 mutations)
Arm group label: EAY191-N2 Cohort II (NF1 mutations)
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)
Arm group label: EAY191-N4 Arm II (RAS pathway mutations)
Arm group label: EAY191-N5 Arm I (neratinib maleate)
Arm group label: EAY191-N5 Arm II (neratinib maleate,palbociclib)

Other name: Blood Pool Scan

Other name: Equilibrium Radionuclide Angiography

Other name: Gated Blood Pool Imaging

Other name: Gated Heart Pool Scan

Other name: MUGA

Other name: MUGA Scan

Other name: Multi-Gated Acquisition Scan

Other name: Radionuclide Ventriculogram Scan

Other name: Radionuclide Ventriculography

Other name: RNV Scan

Other name: RNVG

Other name: SYMA Scanning

Other name: Synchronized Multigated Acquisition Scanning

Intervention type: Procedure
Intervention name: Mutation Carrier Screening
Description: Undergo tumor mutational screening
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)
Arm group label: EAY191-N4 Arm II (RAS pathway mutations)

Intervention type: Drug
Intervention name: Neratinib Maleate
Description: Given PO
Arm group label: EAY191-N5 Arm I (neratinib maleate)
Arm group label: EAY191-N5 Arm II (neratinib maleate,palbociclib)

Other name: 2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:1)

Other name: HKI-272 Maleate

Other name: NERATINIB MALEATE ANHYDROUS

Other name: Nerlynx

Intervention type: Drug
Intervention name: Nilotinib Hydrochloride Monohydrate
Description: Given PO
Arm group label: EAY191-E4 (taxane therapy)

Other name: AMN 107

Other name: AMN-107

Other name: AMN107

Other name: Nilotinib Monohydrochloride Monohydrate

Other name: Tasigna

Intervention type: Drug
Intervention name: Olaparib
Description: Given PO
Arm group label: EAY191-A2 (Cohort 1, Arm A)
Arm group label: EAY191-A2 (Cohort 2, Arm B)
Arm group label: EAY191-A2 (Cohort 2, Arm C)
Arm group label: EAY191-A2 (Cohort 3, Arm D)
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)

Other name: AZD 2281

Other name: AZD-2281

Other name: AZD2281

Other name: KU 0059436

Other name: KU-0059436

Other name: KU0059436

Other name: Lynparza

Other name: Olanib

Other name: Olaparix

Other name: PARP Inhibitor AZD2281

Intervention type: Drug
Intervention name: Oxaliplatin
Description: Given IV
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)

Other name: 1-OHP

Other name: Ai Heng

Other name: Aiheng

Other name: Dacotin

Other name: Dacplat

Other name: Diaminocyclohexane Oxalatoplatinum

Other name: Eloxatin

Other name: Eloxatine

Other name: Elplat

Other name: JM 83

Other name: JM-83

Other name: JM83

Other name: Oxalatoplatin

Other name: Oxalatoplatinum

Other name: RP 54780

Other name: RP-54780

Other name: RP54780

Other name: SR 96669

Other name: SR-96669

Other name: SR96669

Intervention type: Drug
Intervention name: Paclitaxel
Description: Given PO or IV
Arm group label: EAY191-E4 (taxane therapy)
Arm group label: EAY191-S3 (activating AKT mutation)

Other name: Anzatax

Other name: Asotax

Other name: Bristaxol

Other name: Praxel

Other name: Taxol

Other name: Taxol Konzentrat

Intervention type: Drug
Intervention name: Palbociclib
Description: Given PO
Arm group label: EAY191-A3 Combo Cohorts 1, 2, 3, 4 (palbociclib, binimetinib)
Arm group label: EAY191-N5 Arm II (neratinib maleate,palbociclib)

Other name: 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one

Other name: Ibrance

Other name: PD 0332991

Other name: PD 332991

Other name: PD 991

Other name: PD-0332991

Other name: PD0332991

Intervention type: Biological
Intervention name: Panitumumab
Description: Given IV
Arm group label: EAY191-E5 Cohort I Arm A (sotorasib, panitumumab)
Arm group label: EAY191-E5 Cohort II (sotorasib)

Other name: ABX-EGF

Other name: ABX-EGF Monoclonal Antibody

Other name: ABX-EGF, Clone E7.6.3

Other name: E7.6.3

Other name: Human IgG2K Monoclonal Antibody

Other name: MoAb ABX-EGF

Other name: MoAb E7.6.3

Other name: Monoclonal Antibody ABX-EGF

Other name: Monoclonal Antibody E7.6.3

Other name: Vectibix

Intervention type: Procedure
Intervention name: Positron Emission Tomography
Description: Undergo PET
Arm group label: EAY191-A2 (Cohort 1, Arm A)
Arm group label: EAY191-A2 (Cohort 2, Arm B)
Arm group label: EAY191-A2 (Cohort 2, Arm C)
Arm group label: EAY191-A2 (Cohort 3, Arm D)
Arm group label: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)
Arm group label: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)

Other name: Medical Imaging, Positron Emission Tomography

Other name: PET

Other name: PET Scan

Other name: Positron emission tomography (procedure)

Other name: Positron Emission Tomography Scan

Other name: Positron-Emission Tomography

Other name: proton magnetic resonance spectroscopic imaging

Other name: PT

Intervention type: Drug
Intervention name: Selumetinib Sulfate
Description: Given PO
Arm group label: EAY191-N4 Arm I (RAS pathway mutations)
Arm group label: EAY191-N4 Arm II (RAS pathway mutations)

Other name: AZD-6244 Hydrogen Sulfate

Other name: AZD6244 Hydrogen Sulfate

Other name: AZD6244 Hydrogen Sulphate

Other name: Koselugo

Other name: Selumetinib Sulphate

Intervention type: Drug
Intervention name: Sotorasib
Description: Given PO
Arm group label: EAY191-E5 Cohort I Arm A (sotorasib, panitumumab)
Arm group label: EAY191-E5 Cohort I Arm B (sotorasib)
Arm group label: EAY191-E5 Cohort II (sotorasib)

Other name: AMG 510

Other name: AMG-510

Other name: AMG510

Other name: Lumakras

Other name: Lumykras

Summary: This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.

Detailed description: PRIMARY OBJECTIVE: I. To register, allocate, and assign patients to ComboMATCH treatment trials. SECONDARY OBJECTIVES: I. To evaluate the rate of positive outcomes in defined cohorts within treatment trials of treatment combinations including targeted therapies for molecularly defined populations, and also in the subset of treatment trials where the treatments are supported by in vivo models. II. To perform quality control of the patients registered in the form of pathological confirmation of disease and sub-type to confirm diagnosis and treatment arm allocation. SECONDARY CORRELATIVE OBJECTIVES: I. Assess the concordance of the central molecular characterization of the pre-treatment biopsy samples with the genetic readouts from the Designated Laboratories (DLs) for patients enrolled on the ComboMATCH treatment trials. II. To assess how the registration diagnostic tumor mutation profile and pre-treatment biopsy profile compare to the circulating tumor-derived deoxyribonucleic acid (ctDNA) mutation profile from plasma. EXPLORATORY OBJECTIVE: I. Assess association between ComboMATCH treatment trials outcomes (positive or negative) with the type of rationale for the selected drug combinations and the type of rationale for the gene variant/combination for selection (e.g., whether the trial was based on targeted therapies for molecularly defined populations, those that were supported by in vivo models, and those that were supported by empiric clinical data). OUTLINE: REGISTRATION: Patients undergo tumor mutational screening of previously-collected tumor samples for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing. Patients who are 18 years or older and have biopsiable disease undergo a new biopsy for research purposes prior to initiating treatment on the ComboMATCH treatment trial. TREATMENT: Patients with mutations targeted to investigational combination therapies are assigned to 1 of 20 treatment subprotocols. EAY191-N4: Patients with RAS pathway mutant ovarian or endometrial cancer are randomized to 1 of 2 arms. ARM I: Patients receive selumetinib PO and olaparib PO on study. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as echocardiogram (ECHO) or multigated acquisition (MUGA), and computed tomography (CT) scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated. ARM II: Patients receive selumetinib PO on study. Patients who experience progression may elect to cross over to Arm I provided they have not had dose limiting toxicities to monotherapy selumetinib. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as ECHO or MUGA, and CT scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated. EAY191-N2: Patients with inactivating or inferred inactivating NF1 alterations, and hormone receptor positive, HER2-negative metastatic breast cancer. Patients who are fulvestrant naive are assigned to Cohort I, while patients who are fulvestrant resistant are assigned to Cohort II. COHORT I: Patients are randomized to 1 of 2 arms. ARM I:Patients receive fulvestrant intramuscularly (IM) on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles and binimetinib PO twice daily (BID) on days 15 to 28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a CT, magnetic resonance imaging (MRI), or bone scan, ECHO or MUGA, and tumor biopsy, as well as possible blood sample collection during screening and on study. ARM II: Patients receive fulvestrant IM on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who progress on fulvestrant alone may migrate to cohort II if they meet the migration eligibility criteria. Patients not willing to migrate to cohort II will have further therapy at the investigator's discretion. Patients undergo a CT, MRI, or bone scan and tumor biopsy, as well as ECHO or MUGA and possible blood sample collection during screening and on study. COHORT II: Patients receive fulvestrant IM on day 1 of each cycle and binimetinib PO BID on days 15-28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo a CT, MRI, or bone scan, ECHO or MUGA and tumor biopsy, as well as possible blood sample collection during screening and on study. EAY191-E4: Patients with solid tumors who previously underwent taxane therapy. Patients receive nilotinib hydrochloride monohydrate PO twice daily (BID) on days 1-28 and paclitaxel intravenously (IV) over 1 hour on days 1, 8, and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT or MRI during screening or cycle 1 day 1, every 2 cycles for 1 year, every 3 cycles for patients on study for more than 1 year, and every 4 cycles for patients on study for more than 3 years and may also undergo CT or MRI during follow-up every 3 months for 2 years and then every 6 months for 1 year if clinically indicated. Patients also undergo collection of blood samples at baseline, cycle 2 day 1, and optionally at progression as well as tumor biopsy at baseline and optionally at progression. EAY191-A3: Patients with KRAS/NRAS/BRAF mutated low-grade serous ovarian cancer (LGSOC) naive to MEK or CDK4/6 inhibitor therapy are randomized to either combination cohort 1 or monotherapy cohort 1. Patients with LGSOC who have received prior MEK inhibitor therapy are assigned to combination cohort 2. Patients with KRAS/NRAS/HRAS/non-V600E BRAF mutated pancreatic cancer are assigned to combination cohort 3. Patients with all other KRAS/NRAS/HRAS mutated tumor types (excluding LGSOC, non-small cell lung cancer, colorectal cancer, pancreatic, and melanoma) are assigned to combination cohort 4. COMBINATION COHORTS 1, 2, 3, 4: Patients receive palbociclib PO and binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up. MONOTHERAPY COHORT 1: Patients receive binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up. EAY191-S3: Patients with an activating AKT mutation solid tumor. Patients receive paclitaxel IV and ipatasertib PO on study. Patients undergo a CT or MRI and blood collection throughout the trial. Patients also undergo a tumor biopsy during screening and follow-up. EAY191-A6: Patients with RAS/RAF/MEK/ERK mutant biliary tract cancers are randomized to 1 of 2 arms. ARM 1: Patients receive leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo echocardiogram (ECHO) and multigated acquisition scan (MUGA) during screening and on study, a CT with contrast, MRI, or a fludeoxyglucose F-18 positron emission tomography (FDG-PET) during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated. ARM 2: Patients receive binimetinib PO, leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo ECHO and MUGA during screening and on study, a CT with contrast, MRI, or an FDG-PET during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated. EAY191-E5: Patients are assigned to 1 of 2 cohorts. COHORT I: Patients who have never received a KRAS G12C inhibitor are randomized to arms A or B. ARM A: Patients receive sotorasib PO once daily (QD) on days 1-28 and panitumumab intravenously IV on days 1 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study. ARM B: Patients receive sotorasib PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients with disease progression may cross-over to cohort II. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study. COHORT II: Patients who have received a KRAS G12C inhibitor are assigned to arm C. ARM C: Patients receive combination therapy as in Arm A. EAY191-A2: Patients are assigned to 1 of 3 cohorts. COHORT 1: PARP-inhibitor naive patients are assigned to Arm A. ARM A: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression. COHORT 2: PARP-inhibitor naive patients are randomized to 1 of 2 arms. ARM B: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression. ARM C: Patients receive olaparib PO BID on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients experiencing disease progression have the option to migrate to Cohort 3, Arm D. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression. COHORT 3: PARP-inhibitor resistant patients are assigned to Arm D. ARM D: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression. EAY191-N5: Patients are randomized to 1 of 2 arms. ARM I: Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may crossover to Arm II. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study. ARM II: Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 and palbociclib PO QD on days 1-21 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Patient must have measurable disease - Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status between 0-2 OR patient must have Lansky performance status of >= 50% or Karnofsky performance status of >= 50% - Patient must be deemed potentially eligible for a ComboMATCH Treatment Trial as assessed by the enrolling provider - All patients must have sequencing results available from a National Cancer Institute (NCI) credentialed Designated Laboratory (DL) - Patients must have locally advanced or advanced histologically documented solid tumors requiring therapy and meet one of the following criteria: - Patients must have progressed on at least one line of standard systemic therapy OR - Patients whose disease has no standard treatment that has been shown to prolong overall survival - Patient must meet one of the following requirements: - Patients 18 years and older who have tumor amenable to minimal risk image-guided or direct vision biopsy and must be willing and able to undergo a tumor biopsy to obtain samples for research if the patient is to enroll in a ComboMATCH treatment trial OR - Patients 18 years and older who do not have disease that is biopsiable at minimal risk to the patient must confirm availability of an archival tumor tissue specimen for submission for research if the patient enrolls to a ComboMATCH Treatment Trial. This tumor tissue must meet the following criteria: - Tissue must have been collected within 12 months prior to registration to the EAY191 Registration Trial - Patient must not have had a Response Evaluation Criteria in Solid Tumors (RECIST) response (complete response [CR] or partial response [PR]) to any intervening therapy after collection of the tissue - Formalin-fixed paraffin-embedded tumor tissue block(s) or slides must be available OR - Patients under 18 years old must confirm availability of an archival tumor tissue specimen for submission for research if patient enrolls to a ComboMATCH Treatment Trial. This tumor tissue must meet the following criteria: - Formalin-fixed paraffin-embedded tumor tissue block(s) or slides must be available - NOTE: See specific ComboMATCH Treatment Trial protocol for tissue collection and management instructions. Performance of the mandatory research biopsy or submission of pre-trial formalin-fixed paraffin-embedded (FFPE) and collection and submission of the blood specimens for the integrated studies will be performed under the consent authority of the specific treatment trial protocol to which the patient is registered. No procedures to collect specimens for research only are to be performed for patients registered to the EAY191 Registration Trial only - NOTE: Each ComboMATCH Treatment Trial contains specific eligibility criteria. If patient is found to not be eligible for the assigned ComboMATCH Treatment Trial, indication of ineligibility will trigger re-evaluation and potential assignment to another Treatment Trial

Gender: All

Minimum age: N/A

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: University of Alabama at Birmingham Cancer Center

Address:
City: Birmingham
Zip: 35233
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 205-934-0220
Email: tmyrick@uab.edu

Investigator:
Last name: Rebecca C. Arend
Email: Principal Investigator

Facility:
Name: University of South Alabama Mitchell Cancer Institute

Address:
City: Mobile
Zip: 36688
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 251-445-9870
Email: pfrancisco@usouthal.edu

Investigator:
Last name: Ahmed Abdalla
Email: Principal Investigator

Facility:
Name: CTCA at Western Regional Medical Center

Address:
City: Goodyear
Zip: 85338
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 623-207-3000

Investigator:
Last name: Sagun Shrestha
Email: Principal Investigator

Facility:
Name: Kingman Regional Medical Center

Address:
City: Kingman
Zip: 86401
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Mayo Clinic Hospital in Arizona

Address:
City: Phoenix
Zip: 85054
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site Public Contact

Phone: 855-776-0015

Investigator:
Last name: Aaron S. Mansfield
Email: Principal Investigator

Facility:
Name: PCR Oncology

Address:
City: Arroyo Grande
Zip: 93420
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Mercy Cancer Center - Carmichael

Address:
City: Carmichael
Zip: 95608
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 720-874-1881
Email: ResearchInstituteInquiries@CommonSpirit.org

Investigator:
Last name: Shahzad Siddique
Email: Principal Investigator

Facility:
Name: Mercy San Juan Medical Center

Address:
City: Carmichael
Zip: 95608
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 916-556-3301
Email: OncologyResearch@DignityHealth.org

Investigator:
Last name: Shahzad Siddique
Email: Principal Investigator

Facility:
Name: Epic Care-Dublin

Address:
City: Dublin
Zip: 94568
Country: United States

Status: Active, not recruiting

Facility:
Name: Mercy Cancer Center - Elk Grove

Address:
City: Elk Grove
Zip: 95758
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 720-874-1881
Email: ResearchInstituteInquiries@CommonSpirit.org

Investigator:
Last name: Shahzad Siddique
Email: Principal Investigator

Facility:
Name: UC San Diego Health System - Encinitas

Address:
City: Encinitas
Zip: 92024
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 760-536-7700

Investigator:
Last name: Shumei Kato
Email: Principal Investigator

Facility:
Name: UC San Diego Moores Cancer Center

Address:
City: La Jolla
Zip: 92093
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 858-822-5354
Email: cancercto@ucsd.edu

Investigator:
Last name: Shumei Kato
Email: Principal Investigator

Facility:
Name: The Angeles Clinic and Research Institute - West Los Angeles Office

Address:
City: Los Angeles
Zip: 90025
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: ecog.rss@jimmy.harvard.edu

Investigator:
Last name: Navid Hafez
Email: Principal Investigator

Facility:
Name: Cedars Sinai Medical Center

Address:
City: Los Angeles
Zip: 90048
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 310-423-8965

Investigator:
Last name: Navid Hafez
Email: Principal Investigator

Facility:
Name: Contra Costa Regional Medical Center

Address:
City: Martinez
Zip: 94553-3156
Country: United States

Status: Suspended

Facility:
Name: Saint Joseph Hospital - Orange

Address:
City: Orange
Zip: 92868
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 714-734-6220

Investigator:
Last name: Timothy E. Byun
Email: Principal Investigator

Facility:
Name: Stanford Cancer Institute Palo Alto

Address:
City: Palo Alto
Zip: 94304
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 650-498-7061
Email: ccto-office@stanford.edu

Investigator:
Last name: James M. Ford
Email: Principal Investigator

Facility:
Name: VA Palo Alto Health Care System

Address:
City: Palo Alto
Zip: 94304
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-455-0057

Investigator:
Last name: Harlan A. Pinto
Email: Principal Investigator

Facility:
Name: Mercy Cancer Center - Rocklin

Address:
City: Rocklin
Zip: 95765
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 720-874-1881
Email: ResearchInstituteInquiries@CommonSpirit.org

Investigator:
Last name: Shahzad Siddique
Email: Principal Investigator

Facility:
Name: Mercy Cancer Center - Sacramento

Address:
City: Sacramento
Zip: 95816
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 720-874-1881
Email: ResearchInstituteInquiries@CommonSpirit.org

Investigator:
Last name: Shahzad Siddique
Email: Principal Investigator

Facility:
Name: UC San Diego Medical Center - Hillcrest

Address:
City: San Diego
Zip: 92103
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: rhabbaba@health.ucsd.edu

Investigator:
Last name: Shumei Kato
Email: Principal Investigator

Facility:
Name: Sharp Memorial Hospital

Address:
City: San Diego
Zip: 92123
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 858-939-5062
Email: cathy.wood@sharp.com

Investigator:
Last name: Charles H. Redfern
Email: Principal Investigator

Facility:
Name: UCSF Medical Center-Mission Bay

Address:
City: San Francisco
Zip: 94158
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-827-3222
Email: cancertrials@ucsf.edu

Investigator:
Last name: Arun A. Rangaswami
Email: Principal Investigator

Facility:
Name: Saint John's Cancer Institute

Address:
City: Santa Monica
Zip: 90404
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 310-582-7448

Investigator:
Last name: Reva K. Basho
Email: Principal Investigator

Facility:
Name: Epic Care Cyberknife Center

Address:
City: Walnut Creek
Zip: 94597
Country: United States

Status: Active, not recruiting

Facility:
Name: Presbyterian Intercommunity Hospital

Address:
City: Whittier
Zip: 90602
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 562-698-0811

Investigator:
Last name: Christopher R. Foss
Email: Principal Investigator

Facility:
Name: Woodland Memorial Hospital

Address:
City: Woodland
Zip: 95695
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 720-874-1881
Email: ResearchInstituteInquiries@CommonSpirit.org

Investigator:
Last name: Shahzad Siddique
Email: Principal Investigator

Facility:
Name: UCHealth University of Colorado Hospital

Address:
City: Aurora
Zip: 80045
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 720-848-0650

Investigator:
Last name: Robert W. Lentz
Email: Principal Investigator

Facility:
Name: Poudre Valley Hospital

Address:
City: Fort Collins
Zip: 80524
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 970-297-6150

Investigator:
Last name: Robert W. Lentz
Email: Principal Investigator

Facility:
Name: Cancer Care and Hematology-Fort Collins

Address:
City: Fort Collins
Zip: 80528
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: ecog.rss@jimmy.harvard.edu

Investigator:
Last name: Robert W. Lentz
Email: Principal Investigator

Facility:
Name: UCHealth Greeley Hospital

Address:
City: Greeley
Zip: 80631
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: ecog.rss@jimmy.harvard.edu

Investigator:
Last name: Robert W. Lentz
Email: Principal Investigator

Facility:
Name: Medical Center of the Rockies

Address:
City: Loveland
Zip: 80538
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 970-203-7083

Investigator:
Last name: Robert W. Lentz
Email: Principal Investigator

Facility:
Name: Helen F Graham Cancer Center

Address:
City: Newark
Zip: 19713
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 302-623-4450
Email: lbarone@christianacare.org

Investigator:
Last name: Gregory A. Masters
Email: Principal Investigator

Facility:
Name: Medical Oncology Hematology Consultants PA

Address:
City: Newark
Zip: 19713
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 302-623-4450
Email: lbarone@christianacare.org

Investigator:
Last name: Gregory A. Masters
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Aventura

Address:
City: Aventura
Zip: 33180
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 954-461-2180

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Coral Gables

Address:
City: Coral Gables
Zip: 33146
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Deerfield Beach

Address:
City: Deerfield Beach
Zip: 33442
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: Broward Health Medical Center

Address:
City: Fort Lauderdale
Zip: 33316
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 302-651-5572
Email: Allison.bruce@nemours.org

Investigator:
Last name: Mehmet F. Hepgur
Email: Principal Investigator

Facility:
Name: University of Florida Health Science Center - Gainesville

Address:
City: Gainesville
Zip: 32610
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 352-273-8010
Email: cancer-center@ufl.edu

Investigator:
Last name: Thomas J. George
Email: Principal Investigator

Facility:
Name: Mayo Clinic in Florida

Address:
City: Jacksonville
Zip: 32224-9980
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 855-776-0015

Investigator:
Last name: Aaron S. Mansfield
Email: Principal Investigator

Facility:
Name: University of Miami Miller School of Medicine-Sylvester Cancer Center

Address:
City: Miami
Zip: 33136
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Kendall

Address:
City: Miami
Zip: 33176
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Plantation

Address:
City: Plantation
Zip: 33324
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: CTCA at Southeastern Regional Medical Center

Address:
City: Newnan
Zip: 30265
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 770-400-6629

Investigator:
Last name: Natalie S. Godbee
Email: Principal Investigator

Facility:
Name: Hawaii Cancer Care - Westridge

Address:
City: 'Aiea
Zip: 96701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-539-2273
Email: info@hawaiicancercare.com

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: Pali Momi Medical Center

Address:
City: 'Aiea
Zip: 96701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-486-6000

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: The Queen's Medical Center - West Oahu

Address:
City: 'Ewa Beach
Zip: 96706
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: rohta@queens.org

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: Hawaii Cancer Care Inc - Waterfront Plaza

Address:
City: Honolulu
Zip: 96813
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-524-6115
Email: i.webster@hawaiicancercare.com

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: Queen's Cancer Cenrer - POB I

Address:
City: Honolulu
Zip: 96813
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-532-0315

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: Queen's Medical Center

Address:
City: Honolulu
Zip: 96813
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-545-8548

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: Straub Clinic and Hospital

Address:
City: Honolulu
Zip: 96813
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-522-4333

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: Queen's Cancer Center - Kuakini

Address:
City: Honolulu
Zip: 96817
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-531-8521

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: Kapiolani Medical Center for Women and Children

Address:
City: Honolulu
Zip: 96826
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-983-6090

Investigator:
Last name: Jeffrey L. Berenberg
Email: Principal Investigator

Facility:
Name: Saint Alphonsus Cancer Care Center-Boise

Address:
City: Boise
Zip: 83706
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-3671
Email: stephanie.couch@stjoeshealth.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Boise

Address:
City: Boise
Zip: 83712
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Saint Alphonsus Cancer Care Center-Caldwell

Address:
City: Caldwell
Zip: 83605
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-3671
Email: stephanie.couch@stjoeshealth.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Kootenai Health - Coeur d'Alene

Address:
City: Coeur d'Alene
Zip: 83814
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Fruitland

Address:
City: Fruitland
Zip: 83619
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Meridian

Address:
City: Meridian
Zip: 83642
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Saint Alphonsus Cancer Care Center-Nampa

Address:
City: Nampa
Zip: 83687
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Nampa

Address:
City: Nampa
Zip: 83687
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Kootenai Clinic Cancer Services - Post Falls

Address:
City: Post Falls
Zip: 83854
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Kootenai Clinic Cancer Services - Sandpoint

Address:
City: Sandpoint
Zip: 83864
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Twin Falls

Address:
City: Twin Falls
Zip: 83301
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Advocate Good Shepherd Hospital

Address:
City: Barrington
Zip: 60010
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 847-842-4847

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Bloomington

Address:
City: Bloomington
Zip: 61704
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Canton

Address:
City: Canton
Zip: 61520
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Carthage

Address:
City: Carthage
Zip: 62321
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Centralia Oncology Clinic

Address:
City: Centralia
Zip: 62801
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Northwestern University

Address:
City: Chicago
Zip: 60611
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 312-695-1301
Email: cancer@northwestern.edu

Investigator:
Last name: Devalingam Mahalingam
Email: Principal Investigator

Facility:
Name: John H Stroger Jr Hospital of Cook County

Address:
City: Chicago
Zip: 60612
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 312-864-5204

Investigator:
Last name: Thomas E. Lad
Email: Principal Investigator

Facility:
Name: University of Illinois

Address:
City: Chicago
Zip: 60612
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 312-355-3046

Investigator:
Last name: Ryan Nguyen
Email: Principal Investigator

Facility:
Name: University of Chicago Comprehensive Cancer Center

Address:
City: Chicago
Zip: 60637
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 773-702-8222
Email: cancerclinicaltrials@bsd.uchicago.edu

Investigator:
Last name: Ardaman Shergill
Email: Principal Investigator

Facility:
Name: Advocate Illinois Masonic Medical Center

Address:
City: Chicago
Zip: 60657
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 773-296-5360

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: AMG Crystal Lake - Oncology

Address:
City: Crystal Lake
Zip: 60014
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-929-6129
Email: advocateresearch@advocate.com

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Carle at The Riverfront

Address:
City: Danville
Zip: 61832
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-446-5532
Email: Research@Carle.com

Investigator:
Last name: Tanmay Sahai
Email: Principal Investigator

Facility:
Name: Cancer Care Specialists of Illinois - Decatur

Address:
City: Decatur
Zip: 62526
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Decatur Memorial Hospital

Address:
City: Decatur
Zip: 62526
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Northwestern Medicine Cancer Center Kishwaukee

Address:
City: DeKalb
Zip: 60115
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-352-5360
Email: Donald.Smith3@nm.org

Investigator:
Last name: Devalingam Mahalingam
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Dixon

Address:
City: Dixon
Zip: 61021
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 815-285-7800

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate Good Samaritan Hospital

Address:
City: Downers Grove
Zip: 60515
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-275-1270
Email: Barbara.barhamand@advocatehealth.com

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Carle Physician Group-Effingham

Address:
City: Effingham
Zip: 62401
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-446-5532
Email: Research@carle.com

Investigator:
Last name: Tanmay Sahai
Email: Principal Investigator

Facility:
Name: Crossroads Cancer Center

Address:
City: Effingham
Zip: 62401
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate Sherman Hospital

Address:
City: Elgin
Zip: 60123
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 847-429-2907

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Eureka

Address:
City: Eureka
Zip: 61530
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Galesburg

Address:
City: Galesburg
Zip: 61401
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Northwestern Medicine Cancer Center Delnor

Address:
City: Geneva
Zip: 60134
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-352-5360
Email: Donald.Smith3@nm.org

Investigator:
Last name: Devalingam Mahalingam
Email: Principal Investigator

Facility:
Name: Ingalls Memorial Hospital

Address:
City: Harvey
Zip: 60426
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 708-915-4673
Email: clinicaltrials@ingalls.org

Investigator:
Last name: James A. Wallace
Email: Principal Investigator

Facility:
Name: Advocate South Suburban Hospital

Address:
City: Hazel Crest
Zip: 60429
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 708-799-9995

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Kewanee Clinic

Address:
City: Kewanee
Zip: 61443
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Northwestern Medicine Lake Forest Hospital

Address:
City: Lake Forest
Zip: 60045
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: cancertrials@northwestern.edu

Investigator:
Last name: Devalingam Mahalingam
Email: Principal Investigator

Facility:
Name: AMG Libertyville - Oncology

Address:
City: Libertyville
Zip: 60048
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-929-6129
Email: advocateresearch@advocatehealth.com

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Condell Memorial Hospital

Address:
City: Libertyville
Zip: 60048
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-929-6129
Email: advocateresearch@advocatehealth.com

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Macomb

Address:
City: Macomb
Zip: 61455
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Carle Physician Group-Mattoon/Charleston

Address:
City: Mattoon
Zip: 61938
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-446-5532
Email: Research@carle.com

Investigator:
Last name: Tanmay Sahai
Email: Principal Investigator

Facility:
Name: Loyola University Medical Center

Address:
City: Maywood
Zip: 60153
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 708-226-4357

Investigator:
Last name: Kathleen Kennedy
Email: Principal Investigator

Facility:
Name: UC Comprehensive Cancer Center at Silver Cross

Address:
City: New Lenox
Zip: 60451
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 773-702-8222
Email: cancerclinicaltrials@bsd.uchicago.edu

Investigator:
Last name: Ardaman Shergill
Email: Principal Investigator

Facility:
Name: Cancer Care Center of O'Fallon

Address:
City: O'Fallon
Zip: 62269
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate Christ Medical Center

Address:
City: Oak Lawn
Zip: 60453-2699
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-323-8622

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Northwestern Medicine Orland Park

Address:
City: Orland Park
Zip: 60462
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: nctnprogram_rhlccc@northwestern.edu

Investigator:
Last name: Devalingam Mahalingam
Email: Principal Investigator

Facility:
Name: University of Chicago Medicine-Orland Park

Address:
City: Orland Park
Zip: 60462
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 773-702-8222
Email: cancerclinicaltrials@bsd.uchicago.edu

Investigator:
Last name: Ardaman Shergill
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Ottawa Clinic

Address:
City: Ottawa
Zip: 61350
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate Lutheran General Hospital

Address:
City: Park Ridge
Zip: 60068
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 847-384-3621

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Pekin

Address:
City: Pekin
Zip: 61554
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Peoria

Address:
City: Peoria
Zip: 61615
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Peru

Address:
City: Peru
Zip: 61354
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Princeton

Address:
City: Princeton
Zip: 61356
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Memorial Hospital East

Address:
City: Shiloh
Zip: 62269
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 314-747-9912
Email: dschwab@wustl.edu

Investigator:
Last name: Nusayba Bagegni
Email: Principal Investigator

Facility:
Name: Southern Illinois University School of Medicine

Address:
City: Springfield
Zip: 62702
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-545-7929

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Springfield Clinic

Address:
City: Springfield
Zip: 62702
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-444-7541

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Springfield Memorial Hospital

Address:
City: Springfield
Zip: 62781
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-528-7541
Email: pallante.beth@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Carle Cancer Center

Address:
City: Urbana
Zip: 61801
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-446-5532
Email: Research@carle.com

Investigator:
Last name: Tanmay Sahai
Email: Principal Investigator

Facility:
Name: Northwestern Medicine Cancer Center Warrenville

Address:
City: Warrenville
Zip: 60555
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-352-5360
Email: Donald.Smith3@nm.org

Investigator:
Last name: Devalingam Mahalingam
Email: Principal Investigator

Facility:
Name: Illinois CancerCare - Washington

Address:
City: Washington
Zip: 61571
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Midwestern Regional Medical Center

Address:
City: Zion
Zip: 60099
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 844-793-0745

Investigator:
Last name: Evan Pisick
Email: Principal Investigator

Facility:
Name: Reid Health

Address:
City: Richmond
Zip: 47374
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Memorial Hospital of South Bend

Address:
City: South Bend
Zip: 46601
Country: United States

Status: Active, not recruiting

Facility:
Name: Mission Cancer and Blood - Ankeny

Address:
City: Ankeny
Zip: 50023
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 515-282-2921

Investigator:
Last name: Richard L. Deming
Email: Principal Investigator

Facility:
Name: Mercy Hospital

Address:
City: Cedar Rapids
Zip: 52403
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 319-365-4673

Investigator:
Last name: Deborah W. Wilbur
Email: Principal Investigator

Facility:
Name: Oncology Associates at Mercy Medical Center

Address:
City: Cedar Rapids
Zip: 52403
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 319-363-2690

Investigator:
Last name: Deborah W. Wilbur
Email: Principal Investigator

Facility:
Name: Mission Cancer and Blood - Des Moines

Address:
City: Des Moines
Zip: 50309
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 515-241-3305

Investigator:
Last name: Seema Harichand-Herdt
Email: Principal Investigator

Facility:
Name: Mercy Medical Center - Des Moines

Address:
City: Des Moines
Zip: 50314
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 515-358-6613
Email: cancerresearch@mercydesmoines.org

Investigator:
Last name: Richard L. Deming
Email: Principal Investigator

Facility:
Name: Saint Joseph Hospital East

Address:
City: Lexington
Zip: 40509
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 720-874-1881
Email: ResearchInstituteInquiries@CommonSpirit.org

Investigator:
Last name: Shahzad Siddique
Email: Principal Investigator

Facility:
Name: University of Kentucky/Markey Cancer Center

Address:
City: Lexington
Zip: 40536
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 859-257-3379

Investigator:
Last name: Susanne M. Arnold
Email: Principal Investigator

Facility:
Name: Mercy Health - Paducah Cancer Center

Address:
City: Paducah
Zip: 42003
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 270-538-5632
Email: BJWarner@mercy.com

Investigator:
Last name: Nicholas J. DiBella
Email: Principal Investigator

Facility:
Name: Ochsner Medical Center Jefferson

Address:
City: New Orleans
Zip: 70121
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 504-842-8084
Email: Elisemarie.curry@ochsner.org

Investigator:
Last name: John T. Cole
Email: Principal Investigator

Facility:
Name: Harold Alfond Center for Cancer Care

Address:
City: Augusta
Zip: 04330
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 207-626-4855

Investigator:
Last name: Leslie S. Bradford
Email: Principal Investigator

Facility:
Name: Lafayette Family Cancer Center-EMMC

Address:
City: Brewer
Zip: 04412
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-987-3005

Investigator:
Last name: Sarah J. Sinclair
Email: Principal Investigator

Facility:
Name: Maine Medical Center- Scarborough Campus

Address:
City: Scarborough
Zip: 04074
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 207-396-8090
Email: wrighd@mmc.org

Investigator:
Last name: Leslie S. Bradford
Email: Principal Investigator

Facility:
Name: Maine Medical Partners - South Portland

Address:
City: South Portland
Zip: 04106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 207-396-8670
Email: ClinicalResearch@mmc.org

Investigator:
Last name: Leslie S. Bradford
Email: Principal Investigator

Facility:
Name: University of Maryland/Greenebaum Cancer Center

Address:
City: Baltimore
Zip: 21201
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-888-8823

Investigator:
Last name: Ranee Mehra
Email: Principal Investigator

Facility:
Name: National Institutes of Health Clinical Center

Address:
City: Bethesda
Zip: 20892
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-411-1222

Investigator:
Last name: A P. Chen
Email: Principal Investigator

Facility:
Name: UPMC Western Maryland

Address:
City: Cumberland
Zip: 21502
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 240-964-1400

Investigator:
Last name: Adam M. Brufsky
Email: Principal Investigator

Facility:
Name: Tufts Medical Center

Address:
City: Boston
Zip: 02111
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 617-636-5000
Email: ContactUsCancerCenter@TuftsMedicalCenter.org

Investigator:
Last name: Francis W. Nugent
Email: Principal Investigator

Facility:
Name: Beth Israel Deaconess Medical Center

Address:
City: Boston
Zip: 02215
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 617-667-9925

Investigator:
Last name: Gerburg M. Wulf
Email: Principal Investigator

Facility:
Name: Dana-Farber Cancer Institute

Address:
City: Boston
Zip: 02215
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-442-3324

Investigator:
Last name: Geoffrey I. Shapiro
Email: Principal Investigator

Facility:
Name: Baystate Medical Center

Address:
City: Springfield
Zip: 01199
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 413-794-3565
Email: tamara.wrenn@baystatehealth.org

Investigator:
Last name: Tashanna K. Myers
Email: Principal Investigator

Facility:
Name: Trinity Health Saint Joseph Mercy Hospital Ann Arbor

Address:
City: Ann Arbor
Zip: 48106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: University of Michigan Comprehensive Cancer Center

Address:
City: Ann Arbor
Zip: 48109
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-865-1125

Investigator:
Last name: Anne F. Schott
Email: Principal Investigator

Facility:
Name: Bronson Battle Creek

Address:
City: Battle Creek
Zip: 49017
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Trinity Health IHA Medical Group Hematology Oncology - Brighton

Address:
City: Brighton
Zip: 48114
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health Medical Center - Brighton

Address:
City: Brighton
Zip: 48114
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health IHA Medical Group Hematology Oncology - Canton

Address:
City: Canton
Zip: 48188
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health Medical Center - Canton

Address:
City: Canton
Zip: 48188
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Chelsea Hospital

Address:
City: Chelsea
Zip: 48118
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Address:
City: Chelsea
Zip: 48118
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Corewell Health Dearborn Hospital

Address:
City: Dearborn
Zip: 48124
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: Corewell Health Farmington Hills Hospital

Address:
City: Farmington Hills
Zip: 48336
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: Genesee Cancer and Blood Disease Treatment Center

Address:
City: Flint
Zip: 48503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 810-762-8038
Email: wstrong@ghci.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Genesee Hematology Oncology PC

Address:
City: Flint
Zip: 48503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 810-762-8038
Email: wstrong@ghci.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Genesys Hurley Cancer Institute

Address:
City: Flint
Zip: 48503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 810-762-8038
Email: wstrong@ghci.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Hurley Medical Center

Address:
City: Flint
Zip: 48503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 810-762-8038
Email: wstrong@ghci.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Corewell Health Grand Rapids Hospitals - Butterworth Hospital

Address:
City: Grand Rapids
Zip: 49503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Trinity Health Grand Rapids Hospital

Address:
City: Grand Rapids
Zip: 49503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Bronson Methodist Hospital

Address:
City: Kalamazoo
Zip: 49007
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: West Michigan Cancer Center

Address:
City: Kalamazoo
Zip: 49007
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Ascension Borgess Cancer Center

Address:
City: Kalamazoo
Zip: 49009
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Ascension Borgess Hospital

Address:
City: Kalamazoo
Zip: 49048
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: University of Michigan Health - Sparrow Lansing

Address:
City: Lansing
Zip: 48912
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 517-364-3712
Email: harsha.trivedi@umhsparrow.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health Saint Mary Mercy Livonia Hospital

Address:
City: Livonia
Zip: 48154
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Henry Ford Saint John Hospital - Macomb Medical

Address:
City: Macomb
Zip: 48044
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 313-343-3166
Email: kforman1@hfhs.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health Muskegon Hospital

Address:
City: Muskegon
Zip: 49444
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Corewell Health Lakeland Hospitals - Niles Hospital

Address:
City: Niles
Zip: 49120
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Cancer and Hematology Centers of Western Michigan - Norton Shores

Address:
City: Norton Shores
Zip: 49444
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: connie.szczepanek@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Michigan Healthcare Professionals Pontiac

Address:
City: Pontiac
Zip: 48341
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-858-6215
Email: Emily.Crofts@trinity-health.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health Saint Joseph Mercy Oakland Hospital

Address:
City: Pontiac
Zip: 48341
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Corewell Health Reed City Hospital

Address:
City: Reed City
Zip: 49677
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Corewell Health Children's

Address:
City: Royal Oak
Zip: 48073
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: Corewell Health William Beaumont University Hospital

Address:
City: Royal Oak
Zip: 48073
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: MyMichigan Medical Center Saginaw

Address:
City: Saginaw
Zip: 48601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Oncology Hematology Associates of Saginaw Valley PC

Address:
City: Saginaw
Zip: 48604
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 989-907-8411
Email: lori.srebinski@ascension.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center

Address:
City: Saint Joseph
Zip: 49085
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Corewell Health Lakeland Hospitals - Saint Joseph Hospital

Address:
City: Saint Joseph
Zip: 49085
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: MyMichigan Medical Center Tawas

Address:
City: Tawas City
Zip: 48764
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Munson Medical Center

Address:
City: Traverse City
Zip: 49684
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Corewell Health Beaumont Troy Hospital

Address:
City: Troy
Zip: 48085
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: Saint Mary's Oncology/Hematology Associates of West Branch

Address:
City: West Branch
Zip: 48661
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 989-907-8411
Email: lori.srebinski@ascension.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: University of Michigan Health - West

Address:
City: Wyoming
Zip: 49519
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Investigator:
Last name: Kathleen J. Yost
Email: Principal Investigator

Facility:
Name: Huron Gastroenterology PC

Address:
City: Ypsilanti
Zip: 48106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Address:
City: Ypsilanti
Zip: 48197
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Sanford Joe Lueken Cancer Center

Address:
City: Bemidji
Zip: 56601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-333-5000
Email: OncologyClinicalTrialsFargo@sanfordhealth.org

Investigator:
Last name: Daniel Almquist
Email: Principal Investigator

Facility:
Name: Mercy Hospital

Address:
City: Coon Rapids
Zip: 55433
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: David M. King
Email: Principal Investigator

Facility:
Name: Essentia Health - Deer River Clinic

Address:
City: Deer River
Zip: 56636
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Essentia Health Cancer Center

Address:
City: Duluth
Zip: 55805
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Fairview Southdale Hospital

Address:
City: Edina
Zip: 55435
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: David M. King
Email: Principal Investigator

Facility:
Name: Essentia Health Hibbing Clinic

Address:
City: Hibbing
Zip: 55746
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Fairview Clinics and Surgery Center Maple Grove

Address:
City: Maple Grove
Zip: 55369
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: David M. King
Email: Principal Investigator

Facility:
Name: Saint John's Hospital - Healtheast

Address:
City: Maplewood
Zip: 55109
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: David M. King
Email: Principal Investigator

Facility:
Name: Abbott-Northwestern Hospital

Address:
City: Minneapolis
Zip: 55407
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: David M. King
Email: Principal Investigator

Facility:
Name: Mayo Clinic in Rochester

Address:
City: Rochester
Zip: 55905
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 855-776-0015

Investigator:
Last name: Aaron S. Mansfield
Email: Principal Investigator

Facility:
Name: Park Nicollet Clinic - Saint Louis Park

Address:
City: Saint Louis Park
Zip: 55416
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: David M. King
Email: Principal Investigator

Facility:
Name: Regions Hospital

Address:
City: Saint Paul
Zip: 55101
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: David M. King
Email: Principal Investigator

Facility:
Name: United Hospital

Address:
City: Saint Paul
Zip: 55102
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: David M. King
Email: Principal Investigator

Facility:
Name: Essentia Health Sandstone

Address:
City: Sandstone
Zip: 55072
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Essentia Health Virginia Clinic

Address:
City: Virginia
Zip: 55792
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Baptist Memorial Hospital and Cancer Center-Golden Triangle

Address:
City: Columbus
Zip: 39705
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 901-226-1366
Email: BCCclintrials@bmhcc.org

Investigator:
Last name: Andrew J. Benefield
Email: Principal Investigator

Facility:
Name: Baptist Cancer Center-Grenada

Address:
City: Grenada
Zip: 38901
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 901-226-1366
Email: BCCclintrials@bmhcc.org

Investigator:
Last name: Andrew J. Benefield
Email: Principal Investigator

Facility:
Name: Gulfport Memorial Hospital

Address:
City: Gulfport
Zip: 39502
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 504-210-3539
Email: emede1@lsuhsc.edu

Investigator:
Last name: Augusto C. Ochoa
Email: Principal Investigator

Facility:
Name: Baptist Memorial Hospital and Cancer Center-Union County

Address:
City: New Albany
Zip: 38652
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 901-226-1366
Email: BCCclintrials@bmhcc.org

Investigator:
Last name: Andrew J. Benefield
Email: Principal Investigator

Facility:
Name: Baptist Memorial Hospital and Cancer Center-Oxford

Address:
City: Oxford
Zip: 38655
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 901-226-1366
Email: BCCclintrials@bmhcc.org

Investigator:
Last name: Andrew J. Benefield
Email: Principal Investigator

Facility:
Name: Baptist Memorial Hospital and Cancer Center-Desoto

Address:
City: Southhaven
Zip: 38671
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 901-226-1366
Email: BCCclintrials@bmhcc.org

Investigator:
Last name: Andrew J. Benefield
Email: Principal Investigator

Facility:
Name: Saint Francis Medical Center

Address:
City: Cape Girardeau
Zip: 63703
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 573-334-2230
Email: sfmc@sfmc.net

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Saint Luke's Hospital

Address:
City: Chesterfield
Zip: 63017
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 314-205-6936

Investigator:
Last name: Joseph Sokhn
Email: Principal Investigator

Facility:
Name: Siteman Cancer Center at West County Hospital

Address:
City: Creve Coeur
Zip: 63141
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-600-3606
Email: info@siteman.wustl.edu

Investigator:
Last name: Nusayba Bagegni
Email: Principal Investigator

Facility:
Name: Parkland Health Center - Farmington

Address:
City: Farmington
Zip: 63640
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 314-996-5569

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Washington University School of Medicine

Address:
City: Saint Louis
Zip: 63110
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-600-3606
Email: info@siteman.wustl.edu

Investigator:
Last name: Nusayba Bagegni
Email: Principal Investigator

Facility:
Name: Siteman Cancer Center-South County

Address:
City: Saint Louis
Zip: 63129
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-600-3606
Email: info@siteman.wustl.edu

Investigator:
Last name: Nusayba Bagegni
Email: Principal Investigator

Facility:
Name: Missouri Baptist Medical Center

Address:
City: Saint Louis
Zip: 63131
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 314-996-5569

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Siteman Cancer Center at Christian Hospital

Address:
City: Saint Louis
Zip: 63136
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-600-3606
Email: info@siteman.wustl.edu

Investigator:
Last name: Nusayba Bagegni
Email: Principal Investigator

Facility:
Name: Mercy Hospital Saint Louis

Address:
City: Saint Louis
Zip: 63141
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 314-251-7066

Investigator:
Last name: Jay W. Carlson
Email: Principal Investigator

Facility:
Name: Siteman Cancer Center at Saint Peters Hospital

Address:
City: Saint Peters
Zip: 63376
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-600-3606
Email: info@siteman.wustl.edu

Investigator:
Last name: Nusayba Bagegni
Email: Principal Investigator

Facility:
Name: Sainte Genevieve County Memorial Hospital

Address:
City: Sainte Genevieve
Zip: 63670
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 314-996-5569

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Mercy Hospital Springfield

Address:
City: Springfield
Zip: 65804
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 417-269-4520

Investigator:
Last name: Jay W. Carlson
Email: Principal Investigator

Facility:
Name: Missouri Baptist Sullivan Hospital

Address:
City: Sullivan
Zip: 63080
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 314-996-5569

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: BJC Outpatient Center at Sunset Hills

Address:
City: Sunset Hills
Zip: 63127
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 314-996-5569

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Community Hospital of Anaconda

Address:
City: Anaconda
Zip: 59711
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Billings Clinic Cancer Center

Address:
City: Billings
Zip: 59101
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-996-2663
Email: research@billingsclinic.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Bozeman Health Deaconess Hospital

Address:
City: Bozeman
Zip: 59715
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Benefis Sletten Cancer Institute

Address:
City: Great Falls
Zip: 59405
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Logan Health Medical Center

Address:
City: Kalispell
Zip: 59901
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Community Medical Center

Address:
City: Missoula
Zip: 59804
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: OptumCare Cancer Care at Seven Hills

Address:
City: Henderson
Zip: 89052
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: OptumCare Cancer Care at Charleston

Address:
City: Las Vegas
Zip: 89102
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Alliance for Childhood Diseases/Cure 4 the Kids Foundation

Address:
City: Las Vegas
Zip: 89135
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Summerlin Hospital Medical Center

Address:
City: Las Vegas
Zip: 89144
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: OptumCare Cancer Care at Fort Apache

Address:
City: Las Vegas
Zip: 89148
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Renown Regional Medical Center

Address:
City: Reno
Zip: 89502
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Monmouth Medical Center Southern Campus

Address:
City: Lakewood
Zip: 08701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 732-923-6564
Email: mary.danish@rwjbh.org

Investigator:
Last name: Patrick M. Boland
Email: Principal Investigator

Facility:
Name: Saint Barnabas Medical Center

Address:
City: Livingston
Zip: 07039
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 973-322-2934
Email: joanne.loeb@rwjbh.org

Investigator:
Last name: Patrick M. Boland
Email: Principal Investigator

Facility:
Name: Monmouth Medical Center

Address:
City: Long Branch
Zip: 07740
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 732-923-6564
Email: mary.danish@rwjbh.org

Investigator:
Last name: Patrick M. Boland
Email: Principal Investigator

Facility:
Name: Memorial Sloan Kettering Monmouth

Address:
City: Middletown
Zip: 07748
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-639-7592

Investigator:
Last name: Claire F. Friedman
Email: Principal Investigator

Facility:
Name: Rutgers Cancer Institute of New Jersey

Address:
City: New Brunswick
Zip: 08903
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 732-235-7356

Investigator:
Last name: Patrick M. Boland
Email: Principal Investigator

Facility:
Name: Capital Health Medical Center-Hopewell

Address:
City: Pennington
Zip: 08534
Country: United States

Status: Suspended

Facility:
Name: Sidney Kimmel Cancer Center Washington Township

Address:
City: Sewell
Zip: 08080
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 215-600-9151
Email: ONCTrialNow@jefferson.edu

Investigator:
Last name: Jennifer M. Johnson
Email: Principal Investigator

Facility:
Name: Robert Wood Johnson University Hospital Somerset

Address:
City: Somerville
Zip: 08876
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 908-685-2481
Email: Siby.Varughese@rwjbh.org

Investigator:
Last name: Patrick M. Boland
Email: Principal Investigator

Facility:
Name: Community Medical Center

Address:
City: Toms River
Zip: 08755
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 732-557-8294
Email: Lennette.Gonzales@rwjbh.org

Investigator:
Last name: Patrick M. Boland
Email: Principal Investigator

Facility:
Name: University of New Mexico Cancer Center

Address:
City: Albuquerque
Zip: 87106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 505-925-0348
Email: HSC-ClinicalTrialInfo@salud.unm.edu

Investigator:
Last name: Bernard Tawfik
Email: Principal Investigator

Facility:
Name: Montefiore Medical Center-Einstein Campus

Address:
City: Bronx
Zip: 10461
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 718-379-6866
Email: eskwak@montefiore.org

Investigator:
Last name: Balazs Halmos
Email: Principal Investigator

Facility:
Name: Montefiore Medical Center-Weiler Hospital

Address:
City: Bronx
Zip: 10461
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 718-379-6866
Email: eskwak@montefiore.org

Investigator:
Last name: Balazs Halmos
Email: Principal Investigator

Facility:
Name: Montefiore Medical Center - Moses Campus

Address:
City: Bronx
Zip: 10467
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 718-379-6866
Email: eskwak@montefiore.org

Investigator:
Last name: Balazs Halmos
Email: Principal Investigator

Facility:
Name: Roswell Park Cancer Institute

Address:
City: Buffalo
Zip: 14263
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-767-9355
Email: askroswell@roswellpark.org

Investigator:
Last name: Ellis G. Levine
Email: Principal Investigator

Facility:
Name: Memorial Sloan Kettering Commack

Address:
City: Commack
Zip: 11725
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-639-7592

Investigator:
Last name: Claire F. Friedman
Email: Principal Investigator

Facility:
Name: Memorial Sloan Kettering Westchester

Address:
City: Harrison
Zip: 10604
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-639-7592

Investigator:
Last name: Claire F. Friedman
Email: Principal Investigator

Facility:
Name: NYU Langone Hospital - Long Island

Address:
City: Mineola
Zip: 11501
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-263-4432
Email: cancertrials@nyulangone.org

Investigator:
Last name: Kristen R. Spencer
Email: Principal Investigator

Facility:
Name: Laura and Isaac Perlmutter Cancer Center at NYU Langone

Address:
City: New York
Zip: 10016
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: CancerTrials@nyulangone.org

Investigator:
Last name: Kristen R. Spencer
Email: Principal Investigator

Facility:
Name: Mount Sinai Hospital

Address:
City: New York
Zip: 10029
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-824-7309
Email: CCTO@mssm.edu

Investigator:
Last name: Deborah B. Doroshow
Email: Principal Investigator

Facility:
Name: Memorial Sloan Kettering Cancer Center

Address:
City: New York
Zip: 10065
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-639-7592

Investigator:
Last name: Claire F. Friedman
Email: Principal Investigator

Facility:
Name: Pluta Cancer Center

Address:
City: Rochester
Zip: 14623
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: ecog.rss@jimmy.harvard.edu

Investigator:
Last name: Paul M. Barr
Email: Principal Investigator

Facility:
Name: State University of New York Upstate Medical University

Address:
City: Syracuse
Zip: 13210
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 315-464-5476

Investigator:
Last name: Mary J. Cunningham
Email: Principal Investigator

Facility:
Name: Southeastern Medical Oncology Center-Clinton

Address:
City: Clinton
Zip: 28328
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 919-587-9084
Email: jfields@cancersmoc.com

Investigator:
Last name: Samer S. Kasbari
Email: Principal Investigator

Facility:
Name: Duke University Medical Center

Address:
City: Durham
Zip: 27710
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 888-275-3853

Investigator:
Last name: John H. Strickler
Email: Principal Investigator

Facility:
Name: Southeastern Medical Oncology Center-Goldsboro

Address:
City: Goldsboro
Zip: 27534
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 919-587-9084
Email: jfields@cancersmoc.com

Investigator:
Last name: Samer S. Kasbari
Email: Principal Investigator

Facility:
Name: Southeastern Medical Oncology Center-Jacksonville

Address:
City: Jacksonville
Zip: 28546
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 910-587-9084
Email: jfields@cancersmoc.com

Investigator:
Last name: Samer S. Kasbari
Email: Principal Investigator

Facility:
Name: Duke Women's Cancer Care Raleigh

Address:
City: Raleigh
Zip: 27607
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 919-785-4878

Investigator:
Last name: John H. Strickler
Email: Principal Investigator

Facility:
Name: Sanford Bismarck Medical Center

Address:
City: Bismarck
Zip: 58501
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 701-323-5760
Email: OncologyClinicalTrialsFargo@sanfordhealth.org

Investigator:
Last name: Daniel Almquist
Email: Principal Investigator

Facility:
Name: Sanford Broadway Medical Center

Address:
City: Fargo
Zip: 58122
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 701-323-5760
Email: OncologyClinicalTrialsFargo@sanfordhealth.org

Investigator:
Last name: Daniel Almquist
Email: Principal Investigator

Facility:
Name: Sanford Roger Maris Cancer Center

Address:
City: Fargo
Zip: 58122
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 701-234-6161
Email: OncologyClinicalTrialsFargo@sanfordhealth.org

Investigator:
Last name: Daniel Almquist
Email: Principal Investigator

Facility:
Name: UH Seidman Cancer Center at UH Avon Health Center

Address:
City: Avon
Zip: 44011
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-641-2422

Investigator:
Last name: Alberto J. Montero
Email: Principal Investigator

Facility:
Name: UHHS-Chagrin Highlands Medical Center

Address:
City: Beachwood
Zip: 44122
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-641-2422
Email: CTUReferral@UHhospitals.org

Investigator:
Last name: Alberto J. Montero
Email: Principal Investigator

Facility:
Name: Strecker Cancer Center-Belpre

Address:
City: Belpre
Zip: 45714
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Aultman Health Foundation

Address:
City: Canton
Zip: 44710
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 330-363-7274
Email: ClinicalReserachDept@aultman.com

Investigator:
Last name: Sunitha Vemulapalli
Email: Principal Investigator

Facility:
Name: Miami Valley Hospital South

Address:
City: Centerville
Zip: 45459
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Tarek M. Sabagh
Email: Principal Investigator

Facility:
Name: Adena Regional Medical Center

Address:
City: Chillicothe
Zip: 45601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-779-7585
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Good Samaritan Hospital - Cincinnati

Address:
City: Cincinnati
Zip: 45220
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 720-874-1881
Email: ResearchInstituteInquiries@CommonSpirit.org

Investigator:
Last name: Shahzad Siddique
Email: Principal Investigator

Facility:
Name: Cincinnati Children's Hospital Medical Center

Address:
City: Cincinnati
Zip: 45229
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 513-636-2799
Email: cancer@cchmc.org

Investigator:
Last name: Joseph G. Pressey
Email: Principal Investigator

Facility:
Name: Case Western Reserve University

Address:
City: Cleveland
Zip: 44106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-641-2422
Email: CTUReferral@UHhospitals.org

Investigator:
Last name: Alberto J. Montero
Email: Principal Investigator

Facility:
Name: Cleveland Clinic Cancer Center/Fairview Hospital

Address:
City: Cleveland
Zip: 44111
Country: United States

Status: Suspended

Facility:
Name: Cleveland Clinic Foundation

Address:
City: Cleveland
Zip: 44195
Country: United States

Status: Suspended

Facility:
Name: Ohio State University Comprehensive Cancer Center

Address:
City: Columbus
Zip: 43210
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-293-5066
Email: Jamesline@osumc.edu

Investigator:
Last name: Floor Backes
Email: Principal Investigator

Facility:
Name: Mount Carmel East Hospital

Address:
City: Columbus
Zip: 43213
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Columbus Oncology and Hematology Associates Inc

Address:
City: Columbus
Zip: 43214
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: Riverside Methodist Hospital

Address:
City: Columbus
Zip: 43214
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: Grant Medical Center

Address:
City: Columbus
Zip: 43215
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: The Mark H Zangmeister Center

Address:
City: Columbus
Zip: 43219
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Doctors Hospital

Address:
City: Columbus
Zip: 43228
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: Miami Valley Hospital

Address:
City: Dayton
Zip: 45409
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Tarek M. Sabagh
Email: Principal Investigator

Facility:
Name: Premier Blood and Cancer Center

Address:
City: Dayton
Zip: 45409
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-276-8320

Investigator:
Last name: Tarek M. Sabagh
Email: Principal Investigator

Facility:
Name: Dayton Physician LLC - Englewood

Address:
City: Dayton
Zip: 45415
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Miami Valley Hospital North

Address:
City: Dayton
Zip: 45415
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Tarek M. Sabagh
Email: Principal Investigator

Facility:
Name: Delaware Health Center-Grady Cancer Center

Address:
City: Delaware
Zip: 43015
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: Grady Memorial Hospital

Address:
City: Delaware
Zip: 43015
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: Columbus Oncology and Hematology Associates

Address:
City: Dublin
Zip: 43016
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: Dublin Methodist Hospital

Address:
City: Dublin
Zip: 43016
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: Armes Family Cancer Center

Address:
City: Findlay
Zip: 45840
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Atrium Medical Center-Middletown Regional Hospital

Address:
City: Franklin
Zip: 45005-1066
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Tarek M. Sabagh
Email: Principal Investigator

Facility:
Name: Dayton Physicians LLC-Atrium

Address:
City: Franklin
Zip: 45005
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Miami Valley Cancer Care and Infusion

Address:
City: Greenville
Zip: 45331
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-569-7515

Investigator:
Last name: Tarek M. Sabagh
Email: Principal Investigator

Facility:
Name: Zangmeister Center Grove City

Address:
City: Grove City
Zip: 43123
Country: United States

Status: Suspended

Facility:
Name: Greater Dayton Cancer Center

Address:
City: Kettering
Zip: 45409
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Kettering Medical Center

Address:
City: Kettering
Zip: 45429
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Fairfield Medical Center

Address:
City: Lancaster
Zip: 43130
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: OhioHealth Mansfield Hospital

Address:
City: Mansfield
Zip: 44903
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: OhioHealth Marion General Hospital

Address:
City: Marion
Zip: 43302
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: Memorial Hospital

Address:
City: Marysville
Zip: 43040
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Hillcrest Hospital Cancer Center

Address:
City: Mayfield Heights
Zip: 44124
Country: United States

Status: Suspended

Facility:
Name: UH Seidman Cancer Center at Lake Health Mentor Campus

Address:
City: Mentor
Zip: 44060
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-641-2422
Email: CTUReferral@UHhospitals.org

Investigator:
Last name: Alberto J. Montero
Email: Principal Investigator

Facility:
Name: UH Seidman Cancer Center at Southwest General Hospital

Address:
City: Middleburg Heights
Zip: 44130
Country: United States

Status: Active, not recruiting

Facility:
Name: Knox Community Hospital

Address:
City: Mount Vernon
Zip: 43050
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Licking Memorial Hospital

Address:
City: Newark
Zip: 43055
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Mercy Health Perrysburg Cancer Center

Address:
City: Perrysburg
Zip: 43551
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Southern Ohio Medical Center

Address:
City: Portsmouth
Zip: 45662
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Springfield Regional Cancer Center

Address:
City: Springfield
Zip: 45504
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Springfield Regional Medical Center

Address:
City: Springfield
Zip: 45504
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Mercy Health - Saint Anne Hospital

Address:
City: Toledo
Zip: 43623
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Toledo Clinic Cancer Centers-Toledo

Address:
City: Toledo
Zip: 43623
Country: United States

Status: Suspended

Facility:
Name: Upper Valley Medical Center

Address:
City: Troy
Zip: 45373
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Tarek M. Sabagh
Email: Principal Investigator

Facility:
Name: Saint Ann's Hospital

Address:
City: Westerville
Zip: 43081
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Saint Elizabeth Youngstown Hospital

Address:
City: Youngstown
Zip: 44501
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Genesis Healthcare System Cancer Care Center

Address:
City: Zanesville
Zip: 43701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: University of Oklahoma Health Sciences Center

Address:
City: Oklahoma City
Zip: 73104
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 405-271-8777
Email: ou-clinical-trials@ouhsc.edu

Investigator:
Last name: Kathleen N. Moore
Email: Principal Investigator

Facility:
Name: Providence Newberg Medical Center

Address:
City: Newberg
Zip: 97132
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-215-2614
Email: CanRsrchStudies@providence.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Saint Alphonsus Cancer Care Center-Ontario

Address:
City: Ontario
Zip: 97914
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Providence Willamette Falls Medical Center

Address:
City: Oregon City
Zip: 97045
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-215-2614
Email: CanRsrchStudies@providence.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Providence Portland Medical Center

Address:
City: Portland
Zip: 97213
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-215-2614
Email: CanRsrchStudies@providence.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Providence Saint Vincent Medical Center

Address:
City: Portland
Zip: 97225
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-215-2614
Email: CanRsrchStudies@providence.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Oregon Health and Science University

Address:
City: Portland
Zip: 97239
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-494-1080
Email: trials@ohsu.edu

Investigator:
Last name: Christopher W. Ryan
Email: Principal Investigator

Facility:
Name: Lehigh Valley Hospital-Cedar Crest

Address:
City: Allentown
Zip: 18103
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 610-402-9543
Email: Morgan_M.Horton@lvhn.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: UPMC Altoona

Address:
City: Altoona
Zip: 16601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: ecog.rss@jimmy.harvard.edu

Investigator:
Last name: Adam M. Brufsky
Email: Principal Investigator

Facility:
Name: Lehigh Valley Hospital - Muhlenberg

Address:
City: Bethlehem
Zip: 18017
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 610-402-9543
Email: Morgan_M.Horton@lvhn.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Bryn Mawr Hospital

Address:
City: Bryn Mawr
Zip: 19010
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 484-476-2649
Email: turzoe@mlhs.org

Investigator:
Last name: Paul B. Gilman
Email: Principal Investigator

Facility:
Name: Pocono Medical Center

Address:
City: East Stroudsburg
Zip: 18301
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 610-402-9543
Email: Morgan_M.Horton@lvhn.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: UPMC Hillman Cancer Center Erie

Address:
City: Erie
Zip: 16505
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-389-5208
Email: haneydl@upmc.edu

Investigator:
Last name: Adam M. Brufsky
Email: Principal Investigator

Facility:
Name: UPMC Cancer Centers - Arnold Palmer Pavilion

Address:
City: Greensburg
Zip: 15601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 724-838-1900

Investigator:
Last name: Adam M. Brufsky
Email: Principal Investigator

Facility:
Name: UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion

Address:
City: Mechanicsburg
Zip: 17050
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-389-5208
Email: haneydl@upmc.edu

Investigator:
Last name: Adam M. Brufsky
Email: Principal Investigator

Facility:
Name: Riddle Memorial Hospital

Address:
City: Media
Zip: 19063
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 484-476-2649
Email: turzoe@mlhs.org

Investigator:
Last name: Paul B. Gilman
Email: Principal Investigator

Facility:
Name: UPMC Hillman Cancer Center - Monroeville

Address:
City: Monroeville
Zip: 15146
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-389-5208
Email: haneydl@upmc.edu

Investigator:
Last name: Adam M. Brufsky
Email: Principal Investigator

Facility:
Name: Paoli Memorial Hospital

Address:
City: Paoli
Zip: 19301
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 484-476-2649
Email: turzoe@mlhs.org

Investigator:
Last name: Paul B. Gilman
Email: Principal Investigator

Facility:
Name: Pennsylvania Hospital

Address:
City: Philadelphia
Zip: 19107
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 855-216-0098
Email: PennCancerTrials@careboxhealth.com

Investigator:
Last name: Mark S. Diamond
Email: Principal Investigator

Facility:
Name: Thomas Jefferson University Hospital

Address:
City: Philadelphia
Zip: 19107
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 215-600-9151
Email: ONCTrialNow@jefferson.edu

Investigator:
Last name: Jennifer M. Johnson
Email: Principal Investigator

Facility:
Name: Fox Chase Cancer Center

Address:
City: Philadelphia
Zip: 19111
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 215-728-4790

Investigator:
Last name: Angela Jain
Email: Principal Investigator

Facility:
Name: University of Pittsburgh Cancer Institute (UPCI)

Address:
City: Pittsburgh
Zip: 15232
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-647-8073

Investigator:
Last name: Adam M. Brufsky
Email: Principal Investigator

Facility:
Name: UPMC-Passavant Hospital

Address:
City: Pittsburgh
Zip: 15237
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-367-6454

Investigator:
Last name: Adam M. Brufsky
Email: Principal Investigator

Facility:
Name: Guthrie Medical Group PC-Robert Packer Hospital

Address:
City: Sayre
Zip: 18840
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-836-0388

Investigator:
Last name: Joyson Poulose
Email: Principal Investigator

Facility:
Name: Asplundh Cancer Pavilion

Address:
City: Willow Grove
Zip: 19090
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 215-600-9151
Email: ONCTrialNow@jefferson.edu

Investigator:
Last name: Jennifer M. Johnson
Email: Principal Investigator

Facility:
Name: Lankenau Medical Center

Address:
City: Wynnewood
Zip: 19096
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 484-476-2649
Email: turzoe@mlhs.org

Investigator:
Last name: Paul B. Gilman
Email: Principal Investigator

Facility:
Name: Women and Infants Hospital

Address:
City: Providence
Zip: 02905
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 401-274-1122

Investigator:
Last name: Paul A. DiSilvestro
Email: Principal Investigator

Facility:
Name: Prisma Health Cancer Institute - Spartanburg

Address:
City: Boiling Springs
Zip: 29316
Country: United States

Status: Suspended

Facility:
Name: Prisma Health Richland Hospital

Address:
City: Columbia
Zip: 29203
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 864-241-6251

Investigator:
Last name: Ki Y. Chung
Email: Principal Investigator

Facility:
Name: Prisma Health Cancer Institute - Easley

Address:
City: Easley
Zip: 29640
Country: United States

Status: Suspended

Facility:
Name: BI-LO Charities Children's Cancer Center

Address:
City: Greenville
Zip: 29605
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 864-241-6251

Investigator:
Last name: Ki Y. Chung
Email: Principal Investigator

Facility:
Name: Prisma Health Cancer Institute - Butternut

Address:
City: Greenville
Zip: 29605
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 864-241-6251

Investigator:
Last name: Ki Y. Chung
Email: Principal Investigator

Facility:
Name: Prisma Health Cancer Institute - Faris

Address:
City: Greenville
Zip: 29605
Country: United States

Status: Suspended

Facility:
Name: Prisma Health Cancer Institute - Eastside

Address:
City: Greenville
Zip: 29615
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 864-241-6251

Investigator:
Last name: Ki Y. Chung
Email: Principal Investigator

Facility:
Name: Prisma Health Cancer Institute - Greer

Address:
City: Greer
Zip: 29650
Country: United States

Status: Suspended

Facility:
Name: Prisma Health Cancer Institute - Seneca

Address:
City: Seneca
Zip: 29672
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 864-241-6251

Investigator:
Last name: Ki Y. Chung
Email: Principal Investigator

Facility:
Name: Rapid City Regional Hospital

Address:
City: Rapid City
Zip: 57701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 605-755-2370
Email: research@monument.health

Investigator:
Last name: Abdel-Ghani Azzouqa
Email: Principal Investigator

Facility:
Name: Sanford Cancer Center Oncology Clinic

Address:
City: Sioux Falls
Zip: 57104
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 605-312-3320
Email: OncologyClinicTrialsSF@sanfordhealth.org

Investigator:
Last name: Daniel Almquist
Email: Principal Investigator

Facility:
Name: Sanford USD Medical Center - Sioux Falls

Address:
City: Sioux Falls
Zip: 57117-5134
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 605-312-3320
Email: OncologyClinicalTrialsSF@SanfordHealth.org

Investigator:
Last name: Daniel Almquist
Email: Principal Investigator

Facility:
Name: Baptist Memorial Hospital and Cancer Center-Collierville

Address:
City: Collierville
Zip: 38017
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 901-226-1366
Email: BCCclintrials@bmhcc.org

Investigator:
Last name: Andrew J. Benefield
Email: Principal Investigator

Facility:
Name: Baptist Memorial Hospital and Cancer Center-Memphis

Address:
City: Memphis
Zip: 38120
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 901-226-1366
Email: BCCclintrials@bmhcc.org

Investigator:
Last name: Andrew J. Benefield
Email: Principal Investigator

Facility:
Name: Vanderbilt Breast Center at One Hundred Oaks

Address:
City: Nashville
Zip: 37204
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-811-8480

Investigator:
Last name: Jennifer H. Choe
Email: Principal Investigator

Facility:
Name: Vanderbilt University/Ingram Cancer Center

Address:
City: Nashville
Zip: 37232
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-811-8480

Investigator:
Last name: Jennifer H. Choe
Email: Principal Investigator

Facility:
Name: Hendrick Medical Center

Address:
City: Abilene
Zip: 79601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 325-670-6340

Investigator:
Last name: Mustapha A. Khalife
Email: Principal Investigator

Facility:
Name: Houston Methodist Hospital

Address:
City: Houston
Zip: 77030
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 713-790-2700

Investigator:
Last name: Monisha Singh
Email: Principal Investigator

Facility:
Name: M D Anderson Cancer Center

Address:
City: Houston
Zip: 77030
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-632-6789
Email: askmdanderson@mdanderson.org

Investigator:
Last name: Funda Meric-Bernstam
Email: Principal Investigator

Facility:
Name: Methodist Willowbrook Hospital

Address:
City: Houston
Zip: 77070
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 888-823-5923
Email: ctsucontact@westat.com

Investigator:
Last name: Monisha Singh
Email: Principal Investigator

Facility:
Name: Houston Methodist West Hospital

Address:
City: Houston
Zip: 77094
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 832-522-2873

Investigator:
Last name: Monisha Singh
Email: Principal Investigator

Facility:
Name: Houston Methodist Saint John Hospital

Address:
City: Nassau Bay
Zip: 77058
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 888-823-5923
Email: ctsucontact@westat.com

Investigator:
Last name: Monisha Singh
Email: Principal Investigator

Facility:
Name: Houston Methodist Sugar Land Hospital

Address:
City: Sugar Land
Zip: 77479
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 281-242-2873

Investigator:
Last name: Monisha Singh
Email: Principal Investigator

Facility:
Name: Houston Methodist The Woodlands Hospital

Address:
City: The Woodlands
Zip: 77385
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 713-790-2700
Email: hmthewoodlands@houstonmethodist.org

Investigator:
Last name: Monisha Singh
Email: Principal Investigator

Facility:
Name: University of Virginia Cancer Center

Address:
City: Charlottesville
Zip: 22908
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 434-243-6303
Email: uvacancertrials@hscmail.mcc.virginia.edu

Investigator:
Last name: Matthew J. Reilley
Email: Principal Investigator

Facility:
Name: Inova Schar Cancer Institute

Address:
City: Fairfax
Zip: 22031
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 703-720-5210
Email: Stephanie.VanBebber@inova.org

Investigator:
Last name: Timothy L. Cannon
Email: Principal Investigator

Facility:
Name: Inova Fairfax Hospital

Address:
City: Falls Church
Zip: 22042
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 703-208-6650
Email: Stephanie.VanBebber@inova.org

Investigator:
Last name: Timothy L. Cannon
Email: Principal Investigator

Facility:
Name: Virginia Cancer Institute

Address:
City: Richmond
Zip: 23229
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 804-287-3000
Email: smoore@vacancer.com

Investigator:
Last name: Andrew Poklepovic
Email: Principal Investigator

Facility:
Name: VCU Massey Cancer Center at Stony Point

Address:
City: Richmond
Zip: 23235
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: ctoclinops@vcu.edu

Investigator:
Last name: Andrew Poklepovic
Email: Principal Investigator

Facility:
Name: Virginia Commonwealth University/Massey Cancer Center

Address:
City: Richmond
Zip: 23298
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: CTOclinops@vcu.edu

Investigator:
Last name: Andrew Poklepovic
Email: Principal Investigator

Facility:
Name: Carilion Clinic Gynecological Oncology

Address:
City: Roanoke
Zip: 24016
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 540-985-8510

Investigator:
Last name: Andrew Poklepovic
Email: Principal Investigator

Facility:
Name: VCU Community Memorial Health Center

Address:
City: South Hill
Zip: 23970
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: nemer.elmouallem@vcuhealth.org

Investigator:
Last name: Andrew Poklepovic
Email: Principal Investigator

Facility:
Name: Swedish Cancer Institute-Edmonds

Address:
City: Edmonds
Zip: 98026
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 206-215-3086
Email: PCRC-NCORP@Swedish.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Swedish Cancer Institute-Issaquah

Address:
City: Issaquah
Zip: 98029
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 206-215-3086
Email: PCRC-NCORP@Swedish.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: Valley Medical Center

Address:
City: Renton
Zip: 98055
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 425-228-3440
Email: research@valleymed.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Swedish Medical Center-First Hill

Address:
City: Seattle
Zip: 98122
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 206-215-3086
Email: PCRC-NCORP@Swedish.org

Investigator:
Last name: Alison K. Conlin
Email: Principal Investigator

Facility:
Name: North Star Lodge Cancer Center at Yakima Valley Memorial Hospital

Address:
City: Yakima
Zip: 98902
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 509-574-3535
Email: Memorial-ClinicalTrials@yvmh.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: West Virginia University Charleston Division

Address:
City: Charleston
Zip: 25304
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 304-388-9944

Investigator:
Last name: Ahmed A. Khalid
Email: Principal Investigator

Facility:
Name: Edwards Comprehensive Cancer Center

Address:
City: Huntington
Zip: 25701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 304-399-6566
Email: Christina.Cole@chhi.org

Investigator:
Last name: Toni O. Pacioles
Email: Principal Investigator

Facility:
Name: West Virginia University Healthcare

Address:
City: Morgantown
Zip: 26506
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 304-293-7374
Email: cancertrialsinfo@hsc.wvu.edu

Investigator:
Last name: Mohammed Almubarak
Email: Principal Investigator

Facility:
Name: ThedaCare Regional Cancer Center

Address:
City: Appleton
Zip: 54911
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-364-3604
Email: ResearchDept@thedacare.org

Investigator:
Last name: Matthias Weiss
Email: Principal Investigator

Facility:
Name: ThedaCare Regional Medical Center - Appleton

Address:
City: Appleton
Zip: 54911
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-364-3605
Email: ResearchDept@thedacare.org

Investigator:
Last name: Matthias Weiss
Email: Principal Investigator

Facility:
Name: Duluth Clinic Ashland

Address:
City: Ashland
Zip: 54806
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: ThedaCare Cancer Care - Berlin

Address:
City: Berlin
Zip: 54923
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-364-3605
Email: ResearchDept@thedacare.org

Investigator:
Last name: Matthias Weiss
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Southern Lakes VLCC

Address:
City: Burlington
Zip: 53105
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Marshfield Medical Center-EC Cancer Center

Address:
City: Eau Claire
Zip: 54701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-782-8581
Email: oncology.clinical.trials@marshfieldresearch.org

Investigator:
Last name: Adedayo A. Onitilo
Email: Principal Investigator

Facility:
Name: Aurora Health Care Germantown Health Center

Address:
City: Germantown
Zip: 53022
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Grafton

Address:
City: Grafton
Zip: 53024
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center Green Bay

Address:
City: Green Bay
Zip: 54301
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Brian L. Burnette
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center at Saint Mary's

Address:
City: Green Bay
Zip: 54303
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Brian L. Burnette
Email: Principal Investigator

Facility:
Name: Aurora BayCare Medical Center

Address:
City: Green Bay
Zip: 54311
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Mercyhealth Hospital and Cancer Center - Janesville

Address:
City: Janesville
Zip: 53548
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 608-756-6871
Email: oncologyclinicaltrials@mhemail.org

Investigator:
Last name: Emily G. Robinson
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Kenosha South

Address:
City: Kenosha
Zip: 53142
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Gundersen Lutheran Medical Center

Address:
City: La Crosse
Zip: 54601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 608-775-2385
Email: cancerctr@gundersenhealth.org

Investigator:
Last name: Kurt Oettel
Email: Principal Investigator

Facility:
Name: University of Wisconsin Carbone Cancer Center - Eastpark Medical Center

Address:
City: Madison
Zip: 53718
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-622-8922
Email: clinicaltrials@cancer.wisc.edu

Investigator:
Last name: Nataliya V. Uboha
Email: Principal Investigator

Facility:
Name: University of Wisconsin Carbone Cancer Center - University Hospital

Address:
City: Madison
Zip: 53792
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-622-8922
Email: clinicaltrials@cancer.wisc.edu

Investigator:
Last name: Nataliya V. Uboha
Email: Principal Investigator

Facility:
Name: Aurora Bay Area Medical Group-Marinette

Address:
City: Marinette
Zip: 54143
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Marshfield Medical Center-Marshfield

Address:
City: Marshfield
Zip: 54449
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-782-8581
Email: oncology.clinical.trials@marshfieldresearch.org

Investigator:
Last name: Adedayo A. Onitilo
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Milwaukee

Address:
City: Milwaukee
Zip: 53209
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Saint Luke's Medical Center

Address:
City: Milwaukee
Zip: 53215
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Sinai Medical Center

Address:
City: Milwaukee
Zip: 53233
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Marshfield Medical Center - Minocqua

Address:
City: Minocqua
Zip: 54548
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-782-8581
Email: oncology.clinical.trials@marshfieldresearch.org

Investigator:
Last name: Adedayo A. Onitilo
Email: Principal Investigator

Facility:
Name: ProHealth D N Greenwald Center

Address:
City: Mukwonago
Zip: 53149
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: research.institute@phci.org

Investigator:
Last name: Timothy R. Wassenaar
Email: Principal Investigator

Facility:
Name: ThedaCare Regional Medical Center - Neenah

Address:
City: Neenah
Zip: 54956
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-364-3605
Email: ResearchDept@thedacare.org

Investigator:
Last name: Matthias Weiss
Email: Principal Investigator

Facility:
Name: ThedaCare Cancer Care - New London

Address:
City: New London
Zip: 54961
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-364-3605
Email: ResearchDept@thedacare.org

Investigator:
Last name: Matthias Weiss
Email: Principal Investigator

Facility:
Name: ProHealth Oconomowoc Memorial Hospital

Address:
City: Oconomowoc
Zip: 53066
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 262-928-7878

Investigator:
Last name: Timothy R. Wassenaar
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center at Oconto Falls

Address:
City: Oconto Falls
Zip: 54154
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Brian L. Burnette
Email: Principal Investigator

Facility:
Name: ThedaCare Cancer Care - Oshkosh

Address:
City: Oshkosh
Zip: 54904
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-364-3605
Email: ResearchDept@thedacare.org

Investigator:
Last name: Matthias Weiss
Email: Principal Investigator

Facility:
Name: Vince Lombardi Cancer Clinic - Oshkosh

Address:
City: Oshkosh
Zip: 54904
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Racine

Address:
City: Racine
Zip: 53406
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: ThedaCare Cancer Care - Shawano

Address:
City: Shawano
Zip: 54166
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-364-3605
Email: ResearchDept@thedacare.org

Investigator:
Last name: Matthias Weiss
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center at Sheboygan

Address:
City: Sheboygan
Zip: 53081
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Brian L. Burnette
Email: Principal Investigator

Facility:
Name: Vince Lombardi Cancer Clinic-Sheboygan

Address:
City: Sheboygan
Zip: 53081
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Marshfield Medical Center-River Region at Stevens Point

Address:
City: Stevens Point
Zip: 54482
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-782-8581
Email: oncology.clinical.trials@marshfieldresearch.org

Investigator:
Last name: Adedayo A. Onitilo
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center at Sturgeon Bay

Address:
City: Sturgeon Bay
Zip: 54235-1495
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Brian L. Burnette
Email: Principal Investigator

Facility:
Name: Aurora Medical Center in Summit

Address:
City: Summit
Zip: 53066
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Vince Lombardi Cancer Clinic-Two Rivers

Address:
City: Two Rivers
Zip: 54241
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: UW Cancer Center at ProHealth Care

Address:
City: Waukesha
Zip: 53188
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 262-928-5539
Email: Chanda.miller@phci.org

Investigator:
Last name: Timothy R. Wassenaar
Email: Principal Investigator

Facility:
Name: ThedaCare Cancer Care - Waupaca

Address:
City: Waupaca
Zip: 54981
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-364-3605
Email: ResearchDept@thedacare.org

Investigator:
Last name: Matthias Weiss
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Milwaukee West

Address:
City: Wauwatosa
Zip: 53226
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora West Allis Medical Center

Address:
City: West Allis
Zip: 53227
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Marshfield Medical Center - Weston

Address:
City: Weston
Zip: 54476
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-782-8581
Email: oncology.clinical.trials@marshfieldresearch.org

Investigator:
Last name: Adedayo A. Onitilo
Email: Principal Investigator

Facility:
Name: Puerto Rico Hematology Oncology Group

Address:
City: Bayamon
Zip: 00961
Country: Puerto Rico

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 787-780-2865

Investigator:
Last name: Luis J. Santos Reyes
Email: Principal Investigator

Facility:
Name: Doctors Cancer Center

Address:
City: Manati
Zip: 00674
Country: Puerto Rico

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 787-621-4397

Investigator:
Last name: Luis J. Santos Reyes
Email: Principal Investigator

Facility:
Name: Centro Comprensivo de Cancer de UPR

Address:
City: San Juan
Zip: 00927
Country: Puerto Rico

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: ecog.rss@jimmy.harvard.edu

Investigator:
Last name: Luis J. Santos Reyes
Email: Principal Investigator

Facility:
Name: PROncology

Address:
City: San Juan
Zip: 00927
Country: Puerto Rico

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 787-919-7919
Email: info@PRoncology.com

Investigator:
Last name: Luis J. Santos Reyes
Email: Principal Investigator

Start date: April 7, 2023

Completion date: July 1, 2030

Lead sponsor:
Agency: National Cancer Institute (NCI)
Agency class: NIH

Source: National Cancer Institute (NCI)

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05564377